Picture of Aethlon Medical logo

AEMD — Aethlon Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Aethlon Receives Clearance From Drug Controller General Of India For Potential Phase 1 Trial Of Its Hemopurifier® In Oncology

Oct 10 (Reuters) - Aethlon Medical Inc  AEMD.O :
    * AETHLON RECEIVES CLEARANCE FROM DRUG CONTROLLER GENERAL OF
INDIA
FOR POTENTIAL PHASE 1 TRIAL OF ITS HEMOPURIFIER® IN ONCOLOGY
    * AETHLON:SEES TRIAL TO BEGIN POST INTERNAL IN VITRO BINDING
STUDY
OF RELEVANT TARGETS, APPROVAL BY RESPECTIVE ETHICS BOARDS OF
INTERESTED SITES IN INDIA

Source text for Eikon:  ID:nPn2rR63Da 
Further company coverage:  AEMD.O 

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Aethlon Medical

See all news